Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014360 · ClinicalTrials.gov registry record · Phase 1
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
A Phase 1 study, sponsored by Janssen Research & Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT05014360 is a Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 42 participants.
The verdict
NCT05014360, a Phase 1 study, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of JNJ-64251330 in participants with Familial Adenomatous Polyposis (FAP) on colorectal polyp burden (sum of the polyp diameters).
Interventions
- DRUG JNJ-64251330
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2023-02-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05014360
The ClinicalTrials.gov registry entry for NCT05014360 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JNJ-64251330 is the first listed.
NCT05014360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05014360 about?
NCT05014360 is a clinical study titled "A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis". The purpose of this study is to determine the effect of JNJ-64251330 in participants with Familial Adenomatous Polyposis (FAP) on colorectal polyp burden (sum of the polyp diameters).
What is the current status of trial NCT05014360?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2021-11-10. Estimated completion is 2023-02-15.
What interventions are being tested in trial NCT05014360?
The interventions under investigation include: JNJ-64251330 (DRUG).
Who is sponsoring clinical trial NCT05014360?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.